Luke Hoeppner

13PUBLICATIONS
50CO-AUTHORS
MechanobiologyMolecular targetsPredictive and prognostic markersCancer diagnosisMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 25, 2026
Loss of miRNA-153 promotes EndMT and compromises lung vascular integrity.

|Mar 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Yongyong Yang, Ting-You Wang, Joshua Fry

|Mar 18, 2026
Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non-small cell lung cancer.

Li Wang, Anuradha Pandit, Sk Kayum Alam

|May 09, 2025
Dopamine D<sub>2</sub> receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression.

Sk Kayum Alam, Anuradha Pandit, Li Wang

|Dec 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.

Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang

|Jun 19, 2023
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target.

Marina Ferrari, Li Wang, Luke Hoeppner

Pageof 3

Frequent Collaborators

7 joint publications

Sk Kayum Alam

2 joint publications

Adrian P Mansini

2 joint publications

Jindan Yu

1 joint publications

Abbygail M Coyle